ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

SCLX Scilex Holding Company

1.15
0.06 (5.50%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 625,097
Bid Price 1.12
Ask Price 1.16
News (2)
Day High 1.16

Low
0.7316

52 Week Range

High
8.30

Day Low 1.06
Company Name Stock Ticker Symbol Market Type
Scilex Holding Company SCLX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 5.50% 1.15 19:25:09
Open Price Low Price High Price Close Price Prev Close
1.11 1.06 1.16 1.13 1.09
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,310 625,097 $ 1.10 $ 689,931 - 0.7316 - 8.30
Last Trade Time Type Quantity Stock Price Currency
19:49:41 4 $ 1.1599 USD

Scilex (SCLX) Options Flow Summary

Overall Flow

Bullish

Net Premium

35k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Scilex Holding Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
187.79M 166.19M - 46.74M -114.33M -0.69 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Scilex News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SCLX Message Board. Create One! See More Posts on SCLX Message Board See More Message Board Posts

Historical SCLX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.881.250.851.131,557,1880.2730.68%
1 Month0.861.250.73160.979886823,4510.2933.72%
3 Months1.531.700.73161.211,098,206-0.38-24.84%
6 Months1.012.630.73161.40943,1290.1413.86%
1 Year7.128.300.73162.24839,647-5.97-83.85%
3 Years10.0516.700.73163.77701,920-8.90-88.56%
5 Years10.0516.700.73163.77701,920-8.90-88.56%

Scilex Description

Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. ZTlido (lidocaine topical system) 1.8% is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of neuropathic pain associated with post-herpetic neuralgia. We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYB, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. Our product candidates include SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA TM), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, SP-103 (lidocaine topical system) 5.